跳至主要内容
临床试验/EUCTR2017-004202-18-ES
EUCTR2017-004202-18-ES进行中(未招募)1 期

CRioablation vs Antiarrhythmic Drugs for Persistent Atrial Fibrillation Trial (CRAFT) - CRAFT

Fundación Interhospitalaria para la Investigación Cardiovascular0 个研究点目标入组 196 人开始时间: 2018年1月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
196

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Patients with recurrent persistent AF
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 166
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • Patients with AF for more than one year at baseline
  • FA prior ablation
  • Age> 75 years or <18 years
  • Hyperthyroidism
  • Hypertrophic cardiomyopathy
  • Severe valvular disease (stenosis or regurgitation)
  • Carriers of cardiac valves
  • AP Diameter of AI> 50 mm (left parasternal long axis)
  • Contraindications for anticoagulation
  • Left atrial thrombus
  • Active infection
  • Pregnancy
  • FA secondary to transient, avoidable or correctable causes (hyperthyroidism, pneumonia, pulmonary embolism, drugs, hydroelectrolytic alterations ...)
  • Life expectancy of less than 24 months
  • Participation in another non-purely observational study
  • Patients unable to understand treatment and / or study and / or providing adequate informed consent
  • Any condition, that in the opinion of the physician responsible for the patient, contraindicates any of the treatments of the study

研究者

发起方
Fundación Interhospitalaria para la Investigación Cardiovascular

相似试验